American Journal of Kidney Diseases
Volume 50, Issue 1 , Pages 11-20 , July 2007

An Update on Pruritus Associated With CKD

Received 3 January 2007 ,Accepted 19 March 2007.

References 

  1. Robinson BE. Epidemiology of chronic kidney disease and anemia. J Am Med Dir Assoc. 2006;7(suppl 9):S3–S6
  2. Hamer RA, El Nahas AM. The burden of chronic kidney disease. BMJ. 2006;332:563–564
  3. Incidence of treatment for end-stage renal disease attributed to diabetes mellitus—United States, 1980-1989. MMWR Morb Mortal Wkly Rep. 1992;41:834–837
  4. Nolan CR. Strategies for improving long-term survival in patients with ESRD. J Am Soc Nephrol. 2005;16(suppl 2):S120–S127
  5. Sarnak MJ, Levey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation. 2003;108:2154–2169
  6. Szczech LA, Lazar IL. Projecting the United States ESRD population: Issues regarding treatment of patients with ESRD. Kidney Int. 2004;(Suppl 90):S3–S7
  7. Saxena AK. “Uremic pruritus”: A misnomer. Hemodial Int. 2005;9:416–417
  8. Murphy M, Carmichael AJ. Renal itch. Clin Exp Dermatol. 2000;25:103–106
  9. Hung KY, Shyu RS, Tsai TJ, et al. Viral hepatitis infection should be considered for evaluating uremic pruritus in continuous ambulatory peritoneal dialysis patients. Blood Purif. 1998;16:147–153
  10. Kaptein EM. Thyroid hormone metabolism and thyroid diseases in chronic renal failure. Endocr Rev. 1996;17:45–63
  11. Seiler S. Anemia of chronic renal failure: New treatment alternative. CANNT J. 2000;10:35–38
  12. Lonsdale-Eccles A, Carmichael AJ. Treatment of pruritus associated with systemic disorders in the elderly: A review of the role of new therapies. Drugs Aging. 2003;20:197–208
  13. Ponticelli C, Bencini PL. Uremic pruritus: A review. Nephron. 1992;60:1–5
  14. Pauli-Magnus C, Mikus G, Alscher DM, et al. Naltrexone does not relieve uremic pruritus: Results of a randomized, double-blind, placebo-controlled crossover study. J Am Soc Nephrol. 2000;11:514–519
  15. Young AW, Sweeney EW, David DS, et al. Dermatologic evaluation of pruritus in patients on hemodialysis. N Y State J Med. 1973;73:2670–2674
  16. Narita I, Alchi B, Omori K, et al. Etiology and prognostic significance of severe uremic pruritus in chronic hemodialysis patients. Kidney Int. 2006;69:1626–1632
  17. Pisoni RL, Wikstrom B, Elder SJ, et al. Pruritus in haemodialysis patients: International results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant. 2006;21:3495–3505
  18. Mettang T, Pauli-Magnus C, Alscher DM. Uraemic pruritus—New perspectives and insights from recent trials. Nephrol Dial Transplant. 2002;17:1558–1563
  19. Szepietowski JC, Sikora M, Kusztal M, et al. Uremic pruritus: A clinical study of maintenance hemodialysis patients. J Dermatol. 2002;29:621–627
  20. Dyachenko P, Shustak A, Rozenman D. Hemodialysis-related pruritus and associated cutaneous manifestations. Int J Dermatol. 2006;45:664–667
  21. Mistik S, Utas S, Ferahbas A, et al. An epidemiology study of patients with uremic pruritus. J Eur Acad Dermatol Venereol. 2006;20:672–678
  22. Stahle-Backdahl M. Uremic pruritus (Clinical and experimental studies). Acta Derm Venereol Suppl (Stockh). 1989;145:S1–S38
  23. Silverberg NB, Singh A, Laude TA. Cutaneous manifestations of chronic renal failure in children of color. Pediatr Dermatol. 2001;18:199–204
  24. Yosipovitch G, Goon A, Wee J, et al. The prevalence and clinical characteristics of pruritus among patients with extensive psoriasis. Br J Dermatol. 2000;143:969–973
  25. Yosipovitch G, Zucker I, Boner G, et al. A questionnaire for the assessment of pruritus: Validation in uremic patients. Acta Derm Venereol. 2001;81:108–111
  26. Duque MI, Thevarajah S, Chan YH, et al. Uremic pruritus is associated with higher Kt/V and serum calcium concentration. Clin Nephrol. 2006;66:184–191
  27. Zucker I, Yosipovitch G, David M, et al. Prevalence and characterization of uremic pruritus in patients undergoing hemodialysis: Uremic pruritus is still a major problem for patients with end-stage renal disease. J Am Acad Dermatol. 2003;49:842–846
  28. Lhotta K, Wurzner R, Kronenberg F, et al. Rapid activation of the complement system by cuprophane depends on complement component C4. Kidney Int. 1998;53:1044–1051
  29. Altmeyer P, Kachel HG, Schafer G, et al. [Normalization of uremic skin changes following kidney transplantation]. Hautarzt. 1986;37:217–221
  30. Baker A, Dhawan A, Heaton N. Who needs a liver transplant?. (New disease specific indications) Arch Dis Child. 1998;79:460–464
  31. Gilchrest BA, Rowe JW, Brown RS, et al. Ultraviolet phototherapy of uremic pruritus (Long-term results and possible mechanism of action). Ann Intern Med. 1979;91:17–21
  32. Kuypers DR, Claes K, Evenepoel P, et al. A prospective proof of concept study of the efficacy of tacrolimus ointment on uraemic pruritus (UP) in patients on chronic dialysis therapy. Nephrol Dial Transplant. 2004;19:1895–1901
  33. Pauli-Magnus C, Klumpp S, Alscher DM, et al. Short-term efficacy of tacrolimus ointment in severe uremic pruritus. Perit Dial Int. 2000;20:802–803
  34. Silva SR, Viana PC, Lugon NV, et al. Thalidomide for the treatment of uremic pruritus: A crossover randomized double-blind trial. Nephron. 1994;67:270–273
  35. Garssen J, Vandebriel RJ, De Gruijl FR, et al. UVB exposure-induced systemic modulation of Th1- and Th2-mediated immune responses. Immunology. 1999;97:506–514
  36. Ada S, Seckin D, Budakoglu I, et al. Treatment of uremic pruritus with narrowband ultraviolet B phototherapy: An open pilot study. J Am Acad Dermatol. 2005;53:149–151
  37. Gordon JN, Goggin PM. Thalidomide and its derivatives: emerging from the wilderness. Postgrad Med J. 2003;79:127–132
  38. Norris DA. Mechanisms of action of topical therapies and the rationale for combination therapy. J Am Acad Dermatol. 2005;53(suppl 38):S17–S25
  39. Kimmel M, Alscher DM, Dunst R, et al. The role of micro-inflammation in the pathogenesis of uraemic pruritus in haemodialysis patients. Nephrol Dial Transplant. 2006;21:749–755
  40. Chung SH, Heimburger O, Stenvinkel P, et al. Association between residual renal function, inflammation and patient survival in new peritoneal dialysis patients. Nephrol Dial Transplant. 2003;18:590–597
  41. Qureshi AR, Alvestrand A, Vino-Filho JC, et al. Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients. J Am Soc Nephrol. 2002;13(suppl 1):S28–S36
  42. Yosipovitch G, Greaves MW, Schmelz M. Itch. Lancet. 2003;361:690–694
  43. Ikoma A, Steinhoff M, Stander S, et al. The neurobiology of itch. Nat Rev Neurosci. 2006;7:535–547
  44. Kumagai H, Saruta T, Matsukawa S, et al. Prospects for a novel kappa-opioid receptor agonist, TRK-820, in uremic pruritus. In:  Yosipovitch G,  Greaves MW,  Fleischer JA,  McGlone F editor. Itch, Basic Mechanisms and Therapy. New York, NY: Dekker; 2004;p. 279–286
  45. Peer G, Kivity S, Agami O, et al. Randomised crossover trial of naltrexone in uraemic pruritus. Lancet. 1996;348:1552–1554
  46. Wikström B, Gellert R, Ladefoged SD, et al. Kappa-opioid system in uremic pruritus: Multicenter, randomized, double-blind, placebo-controlled clinical studies. J Am Soc Nephrol. 2005;16:3742–3747
  47. Carmichael AJ, McHugh MM, Martin AM, et al. Serological markers of renal itch in patients receiving long term haemodialysis. Br Med J. 1988;296:1575
  48. Szepietowski JC. Selected elements of the pathogenesis of pruritus in hemodialysis patients: My own study. Med Sci Monit. 1996;2:343–347
  49. Friga V, Linos A, Linos DA. Is aluminum toxicity responsible for uremic pruritus in chronic hemodialysis patients?. Nephron. 1997;75:48–53
  50. Momose A, Kudo S, Sato M, et al. Calcium ions are abnormally distributed in the skin of haemodialysis patients with uraemic pruritus. Nephrol Dial Transplant. 2004;19:2061–2066
  51. Schmelz M, Schmidt R, Bickel A, et al. Specific C-receptors for itch in human skin. J Neurosci. 1997;17:8003–8008
  52. Andrew D, Craig AD. Spinothalamic lamina I neurons selectively sensitive to histamine: A central neural pathway for itch. Nat Neurosci. 2001;4:72–77
  53. Stahle-Backdahl M, Hagermark O, Lins LE. The sensitivity of uremic and normal human skin to histamine. Acta Derm Venereol. 1988;68:230–235
  54. Stahle-Backdahl M. Uremic pruritus (Clinical and experimental studies). Acta Derm Venereol Suppl (Stockh). 1989;145:S1–S38
  55. Fantini F, Baraldi A, Sevignani C, et al. Cutaneous innervation in chronic renal failure patients (An immunohistochemical study). Acta Derm Venereol. 1992;72:102–105
  56. Gunal AI, Ozalp G, Yoldas TK, et al. Gabapentin therapy for pruritus in haemodialysis patients: A randomized, placebo-controlled, double-blind trial. Nephrol Dial Transplant. 2004;19:3137–3139
  57. Manenti L, Vaglio A, Costantino E, et al. Gabapentin in the treatment of uremic itch: An index case and a pilot evaluation. J Nephrol. 2005;18:86–91
  58. Morton CA, Lafferty M, Hau C, et al. Pruritus and skin hydration during dialysis. Nephrol Dial Transplant. 1996;11:2031–2036
  59. Bencini PL, Montagnino G, Citterio A, et al. Cutaneous abnormalities in uremic patients. Nephron. 1985;40:316–321
  60. Johansson O, Hilliges M, Stahle-Backdahl M. Intraepidermal neuron-specific enolase (NSE)-immunoreactive nerve fibres: Evidence for sprouting in uremic patients on maintenance hemodialysis. Neurosci Lett. 1989;99:281–286
  61. Berne B, Vahlquist A, Fischer T, et al. UV treatment of uraemic pruritus reduces the vitamin A content of the skin. Eur J Clin Invest. 1984;14:203–206
  62. Blachley JD, Blankenship DM, Menter A, et al. Uremic pruritus: skin divalent ion content and response to ultraviolet phototherapy. Am J Kidney Dis. 1985;5:237–241
  63. Dimkovic N, Djukanovic L, Radmilovic A, et al. Uremic pruritus and skin mast cells. Nephron. 1992;61:5–9
  64. Rollino C, Goitre M, Piccoli G, et al. What is the role of sensitization in uremic pruritus? (An allergologic study). Nephron. 1991;57:319–322
  65. Hampers CL, Katz AI, Wilson RE, et al. Disappearance of “uremic” itching after subtotal parathyroidectomy. N Engl J Med. 1968;279:695–697
  66. Mamianetti A, Tripodi V, Vescina C, et al. Serum bile acids and pruritus in hemodialysis patients. Clin Nephrol. 2000;53:194–198
  67. Francos GC, Kauh YC, Gittlen SD, et al. Elevated plasma histamine in chronic uremia (Effects of ketotifen on pruritus). Int J Dermatol. 1991;30:884–889
  68. Stockenhuber F, Sunder-Plassmann G, Balcke P. Increased plasma histamine levels in chronic renal failure. N Engl J Med. 1987;317:386
  69. Cho YL, Liu HN, Huang TP, et al. Uremic pruritus: Roles of parathyroid hormone and substance P. J Am Acad Dermatol. 1997;36:538–543
  70. Tarng DC, Cho YL, Liu HN, et al. Hemodialysis-related pruritus: A double-blind, placebo-controlled, crossover study of capsaicin 0.025% cream. Nephron. 1996;72:617–622
  71. Wasik F, Szepietowski JC, Szepietowski T, et al. Relief of uraemic pruritus after balneological therapy with a bath oil containing polidocanol (Balneum Hermal Plus) (An open clinical study). J Dermatol Treatment. 1996;7:231–233
  72. Russo GE, Spaziani M, Guidotti C, et al. [Pruritus in chronic uremic patients in periodic hemodialysis. Treatment with terfenadine (an antagonist of histamine H1 receptors)]. Minerva Urol Nefrol. 1986;38:443–447
  73. Pederson JA, Matter BJ, Czerwinski AW, et al. Relief of idiopathic generalized pruritus in dialysis patients treated with activated oral charcoal. Ann Intern Med. 1980;93:446–448
  74. Ashmore SD, Jones CH, Newstead CG, et al. Ondansetron therapy for uremic pruritus in hemodialysis patients. Am J Kidney Dis. 2000;35:827–831
  75. Silverberg DS, Iaina A, Reisin E, et al. Cholestyramine in uraemic pruritus. Br Med J. 1977;1:752–753
  76. De MS, Cecchin E, Villalta D, et al. Relief of pruritus and decreases in plasma histamine concentrations during erythropoietin therapy in patients with uremia. N Engl J Med. 1992;326:969–974
  77. Bousquet J, Rivory JP, Maheut M, et al. Double-blind, placebo-controlled study of nicergoline in the treatment of pruritus in patients receiving maintenance hemodialysis. J Allergy Clin Immunol. 1989;83:825–828
  78. Tapia L, Cheigh JS, David DS, et al. Pruritus in dialysis patients treated with parenteral lidocaine. N Engl J Med. 1977;296:261–262
  79. Hiroshige K, Kabashima N, Takasugi M, et al. Optimal dialysis improves uremic pruritus. Am J Kidney Dis. 1995;25:413–419
  80. Carmichael AJ, Dickinson F, McHugh MI, et al. Magnesium free dialysis for uraemic pruritus. BMJ. 1988;297:1584–1585
  81. Chou FF, Ho JC, Huang SC, et al. A study on pruritus after parathyroidectomy for secondary hyperparathyroidism. J Am Coll Surg. 2000;190:65–70
  82. Shapiro RS, Stockard HE, Schank RN. Uremic pruritus successfully controlled with acupuncture. Dial Transplant. 1988;17:180–183
  83. Twycross R, Greaves MW, Handwerker H, et al. Itch: Scratching more than the surface. QJM. 2003;96:7–26
  84. Okada K, Matsumoto K. Effect of skin care with an emollient containing a high water content on mild uremic pruritus. Ther Apher Dial. 2004;8:419–422
  85. Yosipovitch G, Tur E, Morduchowicz G, et al. Skin surface pH, moisture, and pruritus in haemodialysis patients. Nephrol Dial Transplant. 1993;8:1129–1132
  86. Stahle-Backdahl M, Hagermark O, Lins LE. Pruritus in patients on maintenance hemodialysis. Acta Med Scand. 1988;224:55–60
  87. Szepietowski JC, Szepietowski T, Reich A. Efficacy and tolerance of the cream containing structured physiological lipids with endocannabinoids in the treatment of uremic pruritus: A preliminary study. Acta Dermatovenerol Croat. 2005;13:97–103
  88. Takwale A, Tan E, Agarwal S, et al. Efficacy and tolerability of borage oil in adults and children with atopic eczema: Randomised, double blind, placebo controlled, parallel group trial. BMJ. 2003;327:1385–1389
  89. Tamimi NA, Mikhail AI, Stevens PE. Role of gamma-linolenic acid in uraemic pruritus. Nephron. 1999;83:170–171
  90. Chen YC, Chiu WT, Wu MS. Therapeutic effect of topical gamma-linolenic acid on refractory uremic pruritus. Am J Kidney Dis. 2006;48:69–76
  91. Iijima S, Otsuka F, Kikuchi H, et al. Oral supplementation with gamma-linolenic acid extracted from Mucor circinelloides improves the deformability of red blood cells in hemodialysis patients. Nephron. 2000;86:122–128
  92. Urbonas A, Schwartz RA, Szepietowski JC. Uremic pruritus—An update. Am J Nephrol. 2001;21:343–350
  93. Duque MI, Yosipovitch G, Fleischer AB, et al. Lack of efficacy of tacrolimus ointment 0.1% for treatment of hemodialysis-related pruritus: A randomized, double-blind, vehicle-controlled study. J Am Acad Dermatol. 2005;52:519–521
  94. Dawn AG, Yosipovitch G. Butorphanol for treatment of intractable pruritus. J Am Acad Dermatol. 2006;54:527–531
  95. Szepietowski JC, Schwartz RA. Uremic pruritus. Int J Dermatol. 1998;37:247–253
  96. Baldo A, Sammarco E, Plaitano R, et al. Narrowband (TL-01) ultraviolet B phototherapy for pruritus in polycythaemia vera. Br J Dermatol. 2002;147:979–981
  97. Larsen J, Haedersdal M, Wulf HC. Scratching and ultraviolet irradiation: An experimental animal model. Photodermatol Photoimmunol Photomed. 1994;10:38–41
  98. Szepietowski JC, Morita A, Tsuji T. Ultraviolet B induces mast cell apoptosis: A hypothetical mechanism of ultraviolet B treatment for uraemic pruritus. Med Hypotheses. 2002;58:167–170

 Originally published online as doi: 10.1053/j.ajkd.2007.03.010 on May 15, 2007.

PII: S0272-6386(07)00643-9

doi: 10.1053/j.ajkd.2007.03.010

American Journal of Kidney Diseases
Volume 50, Issue 1 , Pages 11-20 , July 2007

Article Tools

* Image Usage & Resolution